DPIIT recognised startup Government of India
Startup India
Amwin Pharma Private Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.09 Cr
▲ 10% YoY
Net profit · FY 2025
₹39.72 Lakh
Net margin 4.9%
EBITDA · FY 2025
₹62.61 Lakh
EBITDA margin 7.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
44
Provident fund records
Directors on board
2
As per MCA filings
About Amwin Pharma Private Limited
Data last updated:
Amwin Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24290RJ2020PTC072326. Its GSTIN is 08AAUCA4468M1ZT (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amandeep Singh and Vinay Middha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground Floor 1/51 Kanakpura Ricco Ind.Area Sirsi Road Near Railway Station, Jaipur, Rajasthan, India – 302034.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.09 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹39.72 Lakh (net margin 4.9%) and EBITDA of ₹62.61 Lakh (EBITDA margin 7.7%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years.
The company has about 44 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Amwin Pharma.
Amwin Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0139731). For more details, the company can be reached via its website amwinpharma.com.
Company Details of Amwin Pharma Private Limited
CIN U24290RJ2020PTC072326
Registration Number 072326
Incorporation Date 01 December 2020
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-RJ-17-0139731
Key People
Amandeep Singh Director Vinay Middha Director Recognitions & Rankings of Amwin Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-RJ-17-0139731
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressGround Floor 1/51 Kanakpura Ricco Ind.Area Sirsi Road Near Railway Station, Jaipur, Rajasthan, India – 302034
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Amwin Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Amwin Pharma Private Limited
Amwin Pharma operates one associated brand: AMWIN PHARMA. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures, exports, and wholesales pharmaceutical medicines including tablets and injections. | amwinpharma.com |
Business Activity of Amwin Pharma Private Limited
The main business activity of Amwin Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Amwin Pharma Private Limited FY 2025 filings available
Amwin Pharma Private Limited reported revenue of ₹8.09 Cr (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹8.09 Cr ▲ 10%
Net profit · FY 2025
₹39.72 Lakh margin 4.9%
EBITDA · FY 2025
₹62.61 Lakh margin 7.7%
Compounded Annual Growth Rate (CAGR) of Amwin Pharma Private Limited
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 23%
Revenue has grown at a compounded annual rate (CAGR) of 17% over three years, including 10% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Amwin Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹62.61 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹39.72 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Amwin Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Amwin Pharma are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Amwin Pharma Private Limited
Amwin Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amandeep Singh | Director | 01 Dec 2020 | 5 Years 10 Months | Current |
| Vinay Middha | Director | 01 Dec 2020 | 5 Years 10 Months | Current |
Peer Comparison of Amwin Pharma Private Limited
Amwin Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tanmay Exim Private Limited | ₹8.09 Cr (FY 2025) | •••• | •••• | -56.0% | •••• | Surat, Gujarat, India |
| Hytech Pipe Fitting Private Limited | ₹8.09 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Vadodara, Gujarat, India |
| Raunak Commercial Private Limited | ₹8.09 Cr (FY 2025) | •••• | •••• | 64.0% | •••• | Kolkata, West Bengal, India |
| Sideep Exim Private Limited | ₹8.09 Cr (FY 2024) | •••• | •••• | -45.0% | •••• | Kaliyaganj, West Bengal, India |
| Kakamaa Business House Private Limited | ₹8.09 Cr (FY 2024) | •••• | •••• | -23.0% | •••• | Kirti Nagar, Delhi, India |
| Amwin Pharma Private Limited this company | ₹8.09 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Jaipur, Rajasthan, India |
| Euclion Energy Private Limited | ₹8.09 Cr (FY 2024) | •••• | •••• | -51.0% | •••• | Delhi, India |
| Govindam Ispat Private Limited | ₹8.09 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Raipur, Chhattisgarh, India |
| VKMD Global Solutions Private Limited | ₹8.09 Cr (FY 2025) | •••• | •••• | 119.0% | •••• | Pune, Maharashtra, India |
| Radian Technologies Private Limited | ₹8.09 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Chandigarh, India |
| Bhajanka Apparels Private Limited | ₹8.09 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Amwin Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Amwin Pharma Private Limited
Amwin Pharma Private Limited is audited by Gaurav Aggarwal & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Gaurav Aggarwal & Associates | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Amwin Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Amwin Pharma Private Limited
Amwin Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Amwin Pharma Private Limited
Amwin Pharma Private Limited has a workforce of 44 employees as of Apr 04, 2024.
Employee count
44
Active EPFO establishments
1
Employee growth
12.82%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Amwin Pharma Private Limited
Amwin Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Amandeep Singh was appointed as Director on 01 Dec 2020.
AGM
Amwin Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Amwin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Appointed
Amandeep Singh was appointed as Director.
Appointed
Vinay Middha was appointed as Director.
Incorporation
01 Dec 2020
Amwin Pharma Private Limited was registered on 01 Dec 2020 with Roc Jaipur & aged 5 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Amwin Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Amwin Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Amwin Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Amwin Pharma Private Limited
Amwin Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAUCA4468M1ZT | Rajasthan | Active | 08 Feb 2021 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Amwin Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amwin Pharma Private Limited
Amwin Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 December 2020 (6+ years old) and is registered under CIN U24290RJ2020PTC072326.
Amwin Pharma reported revenue of ₹8.09 Cr for FY 2025 (up 10% YoY).
Amwin Pharma has 2 current directors:
- Amandeep Singh - Director
- Vinay Middha - Director
Amwin Pharma reported a net profit of ₹39.72 Lakh (net margin 4.9%) and EBITDA of ₹62.61 Lakh (EBITDA margin 7.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Amwin Pharma is 17% over three years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Amwin Pharma is 08AAUCA4468M1ZT, registered in Rajasthan.
The CIN (Corporate Identification Number) of Amwin Pharma is U24290RJ2020PTC072326. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amwin Pharma was incorporated on 01 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Amwin Pharma by revenue are Tanmay Exim Private Limited, Hytech Pipe Fitting Private Limited, Raunak Commercial Private Limited, Sideep Exim Private Limited, Kakamaa Business House Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Amandeep Singh was appointed as Director on 01 Dec 2020. Vinay Middha was appointed as Director on 01 Dec 2020.
Yes, Amwin Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).